GLUE icon

Monte Rosa Therapeutics
GLUE

Overview Fund Activity

115 hedge funds and large institutions have $281M invested in Monte Rosa Therapeutics in 2025 Q2 according to their latest regulatory filings, with 27 funds opening new positions, 50 increasing their positions, 17 reducing their positions, and 17 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
115
Holders Change
+10
Holders Change %
+9.52%
% of All Funds
1.54%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
27
Increased
50
Reduced
17
Closed
17
Calls
$483K
Puts
$30K
Net Calls
+$453K
Net Calls Change
+$246K

Top Buyers

1
SCM
Suvretta Capital Management
New York
$15.2M
2
AQR Capital Management
AQR Capital Management
Connecticut
$5.79M
3
Royal Bank of Canada
Royal Bank of Canada
Ontario, Canada
$2.12M
4
Renaissance Technologies
Renaissance Technologies
New York
$2.77M
5
Northern Trust
Northern Trust
Illinois
$3.43M

Top Sellers

1
Fidelity Investments
Fidelity Investments
Massachusetts
$10.3M
2
ACA
Avoro Capital Advisors
New York
$16.8M
3
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
$28.5M
4
RAM
Readystate Asset Management
Illinois
$0
5
Millennium Management
Millennium Management
New York
$291K
Name Holding Trade Value Shares
Change 		Shares
Change %
TC
126
TownSquare Capital
Utah
– -$52.9K -11,391 Closed
Simplex Trading
127
Simplex Trading
Illinois
– -$31K -6,756 Closed
Group One Trading
128
Group One Trading
Illinois
– -$25K -5,398 Closed
CCM
129
Coldstream Capital Management
Washington
– -$1.65K -355 Closed
Northwestern Mutual Wealth Management
130
Northwestern Mutual Wealth Management
Wisconsin
– -$1.39K -300 Closed
AAP
131
Arax Advisory Partners
Colorado
– -$441 -95 Closed
PFBT
132
Parkside Financial Bank & Trust
Missouri
– -$441 -95 Closed
2 3 4 5
6